Dionex wird von Thermo Fisher Scientific übernommen

  • Marc N. Casper, President und CEO, Thermo Fisher Scientific: "The acquisition of Dionex is another example of the great progress we're making in executing on our strategy to accelerate growth. We have invested in technology innovation, Asia expansion and complementary acquisitions - all to strengthen our growth opportunities in attractive end markets. We are focused on these strategic investments because they create value for all our key stakeholders - customers, employees and shareholders." Marc N. Casper, President und CEO, Thermo Fisher Scientific: "The acquisition of Dionex is another example of the great progress we're making in executing on our strategy to accelerate growth. We have invested in technology innovation, Asia expansion and complementary acquisitions - all to strengthen our growth opportunities in attractive end markets. We are focused on these strategic investments because they create value for all our key stakeholders - customers, employees and shareholders."

Thermo Fisher Scientific übernimmt für knapp 1,6 Mrd. Euro ($ 2.1 billion) den Chromatographie-Hersteller Dionex und komplettiert damit sein Portfolio in diesem Bereich mit einem starken Ionenchromatographie- und HPLC-Angebot. Die Akquisition soll im ersten Quartal 2011 abgeschlossen sein.

Die Übernahme von Dionex ist ein weiterer großer Schritt in Thermo's "accelerating growth" Strategie, denn sie bedeutet für Thermo eine Investition in innovative Technologie (IC, LC und Software), Wachstum in Asien (Dionex generiert mehr als ein Drittel seines Umsatzes in Asia-Pacific) und eine Wachstumsmöglichkeit in attraktiven Märkten wie Umwelt-, Lebensmittel- und Wasseranalytik sowie den Life Sciences.

Marc N. Casper, Präsident und CEO, Thermo Fisher:
"We believe the combination of Thermo Fisher and Dionex is extremely compelling from a technology, market and financial perspective. Dionex's strength in chromatography instruments, software and consumables complements our leading positions in mass spectrometry and laboratory information management systems. The transaction, which we expect to be immediately accretive, is consistent with our strategy of accelerating growth by increasing our depth of capabilities to serve attractive end markets. Specifically, it complements our strong presence in China, where we've established the headquarters for our global environmental instruments business and continue to build our commercial infrastructure to meet the needs of customers in growing water quality, consumer safety and life sciences markets."

Frank Witney, Präsident und CEO, Dionex:
"We are pleased to be joining Thermo Fisher and are excited about the opportunities we will have as part of the world leader in serving science. Thermo Fisher's commitment to innovation will fuel our ongoing technology development, and their global manufacturing and commercial presence will significantly strengthen our ability to deliver quality products and services to our customers around the world. This transaction offers immediate and significant value for our shareholders, as well as the opportunity for our customers and employees to benefit from combining two highly complementary organizations.

We look forward to working closely with the Thermo Fisher team to ensure a smooth transition and complete the transaction as expeditiously as possible."


http://ir.thermofisher.com/

Jetzt registrieren!

Die neusten Informationen direkt per Newsletter.

To prevent automated spam submissions leave this field empty.